Trading Signals: LGND Stock Price Prediction and Forecast (Mon. Aug. 10, 2015 - Wed. Sep. 27, 2023)(Ligand Pharmaceuticals Inc)
| LGND latest price $160.1600 (-3.03%) ($158.1900 - $165.1000) on Mon. Apr. 2, 2018. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 1.96% (three month average) | RSI | 25 | Latest Price | $160.1600(-3.03%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | LGND declines -0.1% a day on average for past five trading days. | Weekly Trend | LGND declines -3.9% a week on average for past two weeks. | Market Behavior | Broad based sell-off for large cap. Broad based sell-off for small cap. | Correlated ETFs | Broad market will support LGND advance at 0% a week (0% probability) IBB(60%) IWO(57%) XBI(56%) IWC(54%) IWM(53%) | Factors Impacting LGND price | LGND will decline at least -0.98% in a week (0% probabilities). TLT(-15%) VIXM(-14%) UUP(-8%) GDXJ(-6%) IGOV(-4%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -0.98% (StdDev 1.96%) | Hourly BBV | 0 () | Intraday Trend | -2.7% | | | |
|
Resistance Level | $168.9 | 5 Day Moving Average | $163.89(-2.28%) | 10 Day Moving Average | $164.45(-2.61%) | 20 Day Moving Average | $168.9(-5.17%) | To recent high | -12.3% | To recent low | 15.5% | Market Cap | $2.574b | | | | Ligand Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the development and acquisition of technologies that help pharmaceutical companies to discover and develop medicines. Its products include evomela, IV voriconazole, duavee, viviant/conbriza, nexterone, and noxafil-IV. The company was founded by Ronald M. Evans in 1987 and is headquartered in San Diego, CA. |